Staffan Encrantz, Director, 10% Owner at Sight Sciences, Inc. (SGHT), bought 1,043,710 shares at $3.09 ($3.5M) on 2023-11-24, disclosed to the SEC on 2023-11-28.
Open-market purchase of $3.5M SGHT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.09 | 21,855 | $68K | 1.9% |
| 2 | $3.09 | 21,855 | $68K | 1.9% |
| 3 | $3.31 | 246,331 | $815K | 23.2% |
| 4 | $3.31 | 246,331 | $815K | 23.2% |
| 5 | $3.46 | 253,669 | $878K | 24.9% |
| 6 | $3.46 | 253,669 |
| $878K |
| 24.9% |
| Total | $3.37 avg | 1,043,710 | $3.5M | 100% |
| Filing → |
| SGHT | BUY | 2025-06-06 | $646K | — | Filing → |
| SGHT | BUY | 2025-06-03 | $753K | — | Filing → |
| SGHT | BUY | 2025-05-29 | $904K | — | Filing → |